E. Ada Cavalcanti-Adam is a research group leader at the Institute of Physical Chemistry, University of Heidelberg and head of Central Scientific Facility “Biomaterials and Molecular Biology” at the Max Planck Institute for Intelligent Systems in Stuttgart. Her main research interest is on extracellular stimuli which guide cell structure and functions with a special focus on the role of growth factors on cell adhesion and migration.
I have a PhD degree in Chemical Engineering from The University of Arizona. My research experience is centered in two topics: purification of biomolecules and bionanotechnology. Sometimes I perform simulation of chemical and biochemical processes.
Dr. Jui-Yang Lai received his Ph.D. from the Department of Chemical Engineering, National Tsing Hua University, Taiwan. Since 2014, he is a Full Professor at Chang Gung University, Taiwan. Dr. Lai’s primary research activities are centered on the design and development of functional biomaterials, either from natural or synthetic sources, for ophthalmic use, particularly on tissue engineering, drug delivery, and nanomedicine. His major research projects involve ocular biocompatibility assessment, corneal/retinal cell construct fabrication, topical/intraocular pharmaceutical dosage formulation, and metallic/carbon-based nanotherapeutics evaluation. Dr. Lai has published more than 100 scientific papers in peer-reviewed journals and filed numerous patent applications. He actively participates in the peer review process for scientific publications and also serves as a member of the editorial board of several scholarly journals.
Pengcheng Liu is a member of IEEE, IEEE Robotics and Automation Society (RAS), IEEE Control Systems Society (CSS) and International Federation of Automatic Control (IFAC). He is also a member of the IEEE Technical Committee on Bio Robotics, Soft Robotics, Robot Learning, and Safety, Security and Rescue Robotics. Dr Liu is an Associate Editor of IEEE Access, PeerJ Computer Science, and he received the Global Peer Review Awards from Web of Science in 2019, and the Outstanding Contribution Awards from Elsevier in 2017. He has published over 70 papers on flagship journals and conferences. He was nominated as a regular Funding/Grants reviewer for EPSRC, NIHR and NSFC and he has been leading and involving in several research projects and grants, including EPSRC, Newton Fund, Innovate UK, Horizon 2020, Erasmus Mundus, FP7-PEOPLE, NSFC, etc. He serves as reviewers for over 30 flagship journals and conferences in robotics, AI and control. His research interests include robotics, machine learning, automatic control and optimization.
Dr. Matsakas is currently Senior Lecturer at the Biochemical Process Engineering at Luleå University of Technology (Sweden). He received his PhD in Industrial Biotechnology from the school of Chemical Engineering at National Technical University of Athens (Greece) in 2015. His main research activities focus on the development of methods for the pretreatment and fractionation of lignocellulosic and aquatic biomass and the subsequent conversion of the cellulose, hemicellulose and lignin streams to biofuels, bio-based chemicals and bio-materials through biochemical and (thermo)chemical methods. He is also actively working on the development of mixotrophic and heterotrophic microalgae biorefinery processes for the production of high-added value compounds, such as omega-3 PUFAs, pigments and protein.
Dr. Mourao, a distinguished Brazilian dental surgeon, obtained his Doctor of Dental Surgery (DDS) degree from Universidade Estacio de Sa in 2005. He has over 15 years of private practice experience and has developed expertise in Oral and Maxillofacial Surgery (OMFS) and Implant Dentistry.
Between 2014 and 2019, Dr. Mourao held the rank of Lieutenant (Officer) in the Brazilian Navy. He served as a dentist in the Department of Oral and Maxillofacial Surgery and Implant Dentistry. In addition, he is an Assistant Professor at the Department of Periodontology, Tufts University School of Dental Medicine, in Boston, United States.
Dr. Mourao's academic background encompasses a professorship in the Department of OMFS at Universidade Estacio de Sa from 2007 to 2012. Presently, he teaches in the graduate program in Dentistry at Sao Paulo University (USP) and Biotechnology at Fluminense Federal University (UFF).
He earned a Master's degree in Surgical Sciences (2012) from the School of Medicine at the Federal University of Rio de Janeiro (UFRJ), Brazil, where he acquired extensive experience in animal research with rabbits, rats, and pigs. Furthermore, he obtained a Ph.D. in Dentistry (2017) from UFF, Brazil, conducting clinical trials during his studies.
After his doctoral studies, Dr. Mourao completed two postdoctoral fellowships at UFF in Biotechnology (2017-2021) and Oral and Maxillofacial Surgery (2018-2021). He has also demonstrated a strong aptitude for securing federal and private grants to support research projects.
As a researcher, Dr. Mourao's areas of specialization include blood-derived growth factors, bone regeneration, tissue engineering, bone graft analysis, dental implants, and oral surgery. Additionally, he serves as a reviewer for a wide array of national and international academic journals.
Dr. Prashanth Ravishankar received his PhD in Biomedical Engineering from the University of Arkansas. He is a Research and Development Scientist at Namida Lab Inc.
He has over a decade of experience in areas of Bioengineering, Biomaterials, Mechanobiology, Tissue Engineering, and Bone and Cardiovascular Bioengineering. He has presented at international conferences in the USA, Canada, and Abu Dhabi. He also serves as an editorial member on BMC Research Notes and as a reviewer for journals and conferences.
Nuno Silva completed his BSc in Applied Biology (2007) and received is PhD in Tissue Engineering, Regenerative Medicine and Stem Cells from the University of Minho in 2012. His PhD work consisted on the development of novel approaches for Spinal Cord Injury Repair (SCI) based on biodegradable materials and stem cells. His PhD was carried out in the 3B’s Research Group and in the Centre for Cellular and Biomolecular Research of the University of Toronto. In 2012 he started a post-doc at ICVS dedicated to study the best therapeutic combination to treat the injured spinal cord.
In 2014 he was able to capture national competitive funding and started his own lab. Currently, his team is fully focused on research about SCI, from solving fundamental questions about how SCI affect the systemic immune response to design technological advanced therapies to treat this condition. The team is presently constituted by 1 post-doctoral fellows, 1 MD-PhD student and 5 PhD students.
He is currently an author of 44 papers published in international peer-reviewed journals and is an author of two patents. Nuno Silva has currently more than 2700 citations and an h-index of 23. Additionally he is author of 7 book chapters and has more than 60 communications in national and international conferences. He supervises/supervised 25 post-graduation students. Finally, during his research career, Nuno Silva was able to capture more than two million euros of competitive funding, either in research projects (1.8M) or salary grants (438K). He was honored with international funding from the Wings For Life Foundation and the La Caixa Foundation.